Vaccinex Gross Profit Growth & History (VCNX)
Vaccinex's gross profit was $900,000 for fiscal 2021.
View full Vaccinex company overviewVaccinex annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2021 | 2021-12-31 | $900,000 | $277,000 | +44.46% |
| 2020 | 2020-12-31 | $623,000 | $299,000 | +92.28% |
| 2019 | 2019-12-31 | $324,000 | $633,000 | — |
| 2018 | 2018-12-31 | −$309,000 | −$239,000 | — |
| 2017 | 2017-12-31 | −$70,000 | — | — |
Vaccinex quarterly gross profit
| Fiscal quarter | Period ended | Gross profit | Change | YoY change |
|---|---|---|---|---|
| Q3 2020 | 2020-09-30 | $623,000 | $227,000 | +57.32% |
| Q4 2019 | 2019-12-31 | $0 | $107,000 | — |
| Q3 2019 | 2019-09-30 | $396,000 | $444,000 | — |
| Q2 2019 | 2019-06-30 | $9,000 | $129,000 | — |
| Q1 2019 | 2019-03-31 | −$81,000 | −$47,000 | — |
| Q4 2018 | 2018-12-31 | −$107,000 | — | — |
| Q3 2018 | 2018-09-30 | −$48,000 | — | — |
| Q2 2018 | 2018-06-30 | −$120,000 | — | — |
| Q1 2018 | 2018-03-31 | −$34,000 | — | — |
Vaccinex gross profit trends
Between the periods ended 2017-12-31 and 2021-12-31, Vaccinex's gross profit increased from −$70,000 to $900,000, a change of $970,000. The latest reported quarter, Q3 2020, shows $623,000.
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
SEC-reported and calculated gross profit
TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Vaccinex source filings ↗